GNA11 and hepatocellular carcinoma: Besides mutations, the GNA11 gene promoter was also found to be hypermethylated in hepatocellular carcinoma (HCC) and was proposed as a promising biomarker for diagnosis and targeted therapy (Livingstone et al., 2020).